An EHR-based Platform To Facilitate Outcomes and Research Methods in Cerebrovascular Diseases

NCT04775836 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300000

Last updated 2021-03-01

No results posted yet for this study

Summary

In this protocol, the investigators present methods and preliminary results from the PLATFORM-CVD Study, an EHR-based multicenter cohort. This study will focus on assessing the distribution of major cerebrovascular diseases, determining the risk factors associated with disease incidence and worse in-hospital outcomes, as well as describing the quality of care. Data from this cohort will be used to develop suitable prediction models for cerebrovascular diseases using real-world data and to understand how outcomes for cerebrovascular diseases would change with quality improvement interventions.

Conditions

  • Stroke
  • Cerebrovascular Diseases
  • Cerebral Infarction
  • Cerebral Hemorrhage
  • Transient Ischemic Attack
  • Subarachnoid Hemorrhage

Sponsors & Collaborators

  • Dalian Jiuzhou Century Hospital

    collaborator UNKNOWN
  • Dengzhou Central Hospital

    collaborator UNKNOWN
  • Guangxi Ruikang Hospital

    collaborator OTHER
  • Guangdong Second Provincial General Hospital

    collaborator OTHER
  • Handan Central Hospital

    collaborator OTHER
  • Xunxian People's Hospital

    collaborator UNKNOWN
  • Kaifeng Central Hospital

    collaborator OTHER
  • Laoling People's Hospital

    collaborator UNKNOWN
  • New Area People's Hospital of Luoyang

    collaborator UNKNOWN
  • Chinese Traditional Medicine Hospital of Meishan

    collaborator UNKNOWN
  • Mengjin People's Hospital

    collaborator UNKNOWN
  • Nanyang Central Hospital

    collaborator OTHER
  • Hexigten Banner Mongolian Traditional Chinese Medicine Hospital

    collaborator UNKNOWN
  • Inner Mongolian Hospital of Traditional Chinese Medicine

    collaborator UNKNOWN
  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • Renqiu Kangjixintu Hospital

    collaborator UNKNOWN
  • Shenzhen Second People's Hospital

    collaborator OTHER
  • Wuhan No.1 Hospital

    collaborator OTHER
  • Xingtai City Ninth Hospital

    collaborator UNKNOWN
  • Yilong People's Hospital

    collaborator UNKNOWN
  • Yongcheng City Central Hospital

    collaborator UNKNOWN
  • Chongqing Donghua Hospital

    collaborator UNKNOWN
  • The Second Affiliated Hospital of Luohe Medical College

    collaborator UNKNOWN
  • Ministry of Science and Technology of the People´s Republic of China

    lead OTHER_GOV

Principal Investigators

  • Zi-Xiao Li, PhD · Beijing Tiantan Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04775836 on ClinicalTrials.gov